Published in Medical Letter on the CDC and FDA, January 31st, 2000
Trileptal belongs to the class of drugs known as anticonvulsant or antiepileptic drugs (AEDs). The medication is indicated for the treatment of partial seizures as monotherapy in adults or adjunctive therapy (use in combination with other AEDs) in adults and children as young as 4 years of age.
"Currently, approximately 30-50% of people with epilepsy may continue to experience seizures despite treatment with the medications now available, and for those who are able to control their...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA